drugs were unveiled last year and it was aimed at meeting people's needs, from lutetium 64 or copper 64 psma, which was used in various fields, to the radio nuclide that you even unveiled, which was also used in industrial fields. in the context of the program on the radio we are expanding, and we are working on radiopharmaceuticals that we cannot import into the country, like the 64 psma that we could not import, and now we have made it available to the people. you can see that radiopharmaceuticals are continuously being researched, that is, even the radiopharmaceuticals that are currently being produced. we have mentioned that research is on our agenda to improve and increase its quality. i have already said that to the dear people who are on radio daru, the efforts of our colleagues in the department.

from copper 64, let's take lutetium or copper 64 psma, which was used in various fields, to the radio nuclide that we even unveiled, which was also used in industrial fields. in terms of the program we have on the radio, we are expanding, and there are radio stations that we cannot bring into the country, like the one in 64. and now we have made it available to the people, you can see that radiopharmaceuticals are continuously being researched, that is, even radiopharmaceuticals now we have the product of his research in order to improve and increase its quality . i have already told you, dear people, that on radio daru , the efforts of our colleagues are in the diagnosis department. diagnostic and treatment are being used in the country as a complementary step in the research projects . now , there are approximately 20 radiopharmaceuticals in the clinical phase in different stages. well , this is a huge development, that is 40%, and we have an increase in the number of radiopharmaceuticals. in fact, we have found the diversity of radiopharmaceuticals. this is the second point and the

we can get lutetium or copper 64 psma from copper 64, which was used in various fields, until the radio nuclide that you even unveiled, which is in the form of his research is constantly continuing, that is, even the radiopharmaceuticals that are now produced by his research to improve and increase the quality of the situation. we have on our agenda. i have already said to the dear people that on radio daru, the effort of our colleagues is to increase the accuracy of the body in the diagnostic department , and to increase the effectiveness of therapeutic drugs in the radio department. these two important components have a quantitative and qualitative goal. well, we now have 50 radio drugs, which explains one million people a year. they are using these in the diagnostic and treatment sectors in the country, and as a complementary step, the projects that were in research , now there are approximately 20 radiopharmaceuticals in the clinical phase at different stages. and we are increasing the diversity of our existing radio medicine . this is the second point. and the third point is that w